T cell receptor display

A cell receptor, surface display technology, applied in the field of protein-based particles, which can solve problems such as reducing the size of heterologous DNA sequences

Active Publication Date: 2005-12-28
IMMUNOCORE LTD +1
View PDF10 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the size of the heterologous DNA sequence that can be

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • T cell receptor display
  • T cell receptor display
  • T cell receptor display

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1-A6

[0268] Example 1-A6 Primer Design and Mutagenesis of Tax TCR α and β Chains to Introduce Cysteine ​​Residues Required for New Interchain Disulfide Bond Formation

[0269] To mutate A6 Tax threonine 48 of exon 1 in TRAC*01 to cysteine, the following primers were designed (mutations are indicated by lowercase letters):

[0270] 5'-C ACA GAC AAA tgT GTG CTA GAC AT (SEQ ID 35)

[0271] 5'-AT GTC TAG CAC Aca TTT GTC TGT G (SEQ ID 36)

[0272] To mutate A6 Tax serine 57 of exon 1 in TRBC1*01 and TRBC2*01 to cysteine, the following primers were designed (mutations are indicated by lowercase letters):

[0273] 5'-C AGT GGG GTC tGC ACA GAC CC (SEQ ID 37)

[0274] 5'-GG GTC TGT Gca GAC ​​CCC ACT G (SEQ ID 38)

[0275] PCR mutagenesis

[0276] Expression plasmids containing A6 Tax TCR α or β chain genes were mutated as described below using α chain primers or β chain primers, respectively.

[0277] Mix 100 ng of plasmid with 5 µl of 10 mM dNTPs, 25 µl of 10xPfu buffer (Stratagene), ...

Embodiment 2

[0278] Example 2 - Construction of phage display vector and cloning of A6 TCRα and β chains into the phagemid vector

[0279] To display the heterodimeric A6 TCR containing non-native interchain disulfide bonds on filamentous phage particles, a phagemid vector was constructed to express the heterodimeric A6 TCR containing non-native interchain disulfide bonds and phage Fusion protein composed of coat protein. These vectors contain a pUC19 origin, an M13 origin, a bla (ampicillin resistance) gene, Lac promoter / operator and a CAP binding site. The design of these vectors is outlined in Figure 3, which depicts vectors encoding A6 TCR beta chain-g3 or A6 TCR beta chain-g8 fusion proteins in addition to soluble A6 TCR alpha chain. A6 TCR α and β chains prepared in Example 1 and shown in Figures 1a and 1b containing mutations incorporating additional cysteine ​​residues required for formation of new interchain disulfide bonds were used to generate Source of A6 TCR α and β chains f...

Embodiment 3

[0284] Example 3-Expression of fusion protein of bacterial coat protein and heterologous dimer A6 TCR in Escherichia coli

[0285] To validate the constructs generated in Example 2, phages displaying non-native interchain disulfides were prepared using the phage previously described for generating scFv displaying antibodies (Li et al., 2000, Journal of Immunological Methods 236:133-146) and subsequent modifications to produce scFv containing non-native interchain disulfides. Keyed A6 TCR phage particles. E. coli XL-1-Blue cells containing the pEX746:A6 phagemid (i.e., the phagemid encoding the soluble A6 TCR alpha chain and the A6 TCR beta chain fused to the phage gIII protein produced as described in Example 2) It was used to inoculate 5 ml of Lbatg (Lennox L medium containing 100 μg / ml ampicillin, 12.5 μg / ml tetracycline and 2% glucose), and then the culture was cultured overnight (16 hours) at 37° C. with shaking. 50 µl of overnight culture was used to inoculate 5 ml of TY...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A proteinaceous particle such as a bacteriophage, ribosome or cell displaying a T cell receptor (TCR) on its surface. The displayed TCR is preferably a heterodimer with non-native disulfide bonds between constant domain residues. Such display particles can be used to build diverse TCR libraries to identify high affinity TCRs. Several high affinity TCRs are disclosed.

Description

[0001] The present invention relates to particles displaying proteinaceous properties of the T cell receptor (TCR), such as phage or ribosomal particles, and different libraries thereof. Background of the invention [0002] Natural T Cell Receptor (TCR) [0003] As described in eg WO99 / 60120, TCR mediates T cell recognition of specific major histocompatibility complex (MHC)-peptide complexes, which is the basis for the functioning of cellular immunity of the immune system. [0004] Antibodies and TCRs are the only two molecules that recognize antigens in a specific manner, and TCRs are thus the only receptors for specific antigenic peptides presented by MHC, foreign peptides are often the only marker of intracellular abnormalities. T cell recognition occurs when direct physical contact occurs between T cells and antigen-presenting cells (APCs), and is initiated by ligation of antigen-specific TCRs to pMHC complexes. [0005] The native TCR is a heterodimeric cell surface prot...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K14/705
Inventor B·K·雅各布森T·B·安德森P·E·莫洛伊李懿J·M·伯尔特
Owner IMMUNOCORE LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products